| Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964) |
|---|
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | CA2669874A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/20/2008 | US7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/20/2008 | CA2344308C Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 05/14/2008 | EP1919861A2 Compounds for treating alzheimer's disease |
| 05/14/2008 | CN101177418A Method for synthesizing thiazine ketone |
| 05/14/2008 | CN100387584C Preparation method of methazolamide |
| 05/13/2008 | US7371771 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase |
| 05/13/2008 | US7371746 1,2,4-Thiadiazole compounds and pests controlling composition containing the same |
| 05/08/2008 | WO2008036308A3 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| 05/07/2008 | EP1917323A1 Novel materials for organic electroluminescent devices |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008049864A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 05/02/2008 | CA2667545A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| 04/30/2008 | EP1915907A2 An agricultural and horticultural disease controller |
| 04/30/2008 | EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365063 5-HT6 receptor and/or 5-HT2A receptor modulators; CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, sleep disorders, feeding disorders |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/24/2008 | US20080096938 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 04/24/2008 | US20080096918 2-(3-(4-benzyloxybenzyl)-2-oxoimidazolidin-1-yl)-N-hydroxy-3-methylbutyramide; N-hydroxy-3-methyl-2-{2-oxo-3-(4-(pyridin-4-ylmethoxy)benzyl)imidazolidin-1-yl}butyramide with trifluoroacetic acid ; osteoarthrosis and rheumatoid arthritis; TNF- alpha converting enzyme (TACE) inhibitor |
| 04/23/2008 | EP1914225A1 Salt molten at room temperature and display device |
| 04/23/2008 | EP1912958A1 Substituted malononitrile compounds for combating animal pests |
| 04/23/2008 | EP1812412B1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 04/23/2008 | EP1689493A4 Calcitonin gene related peptide receptor antagonists |
| 04/23/2008 | EP1054875B1 Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines |
| 04/23/2008 | CN100383133C Thiadizole dimer additives and lubricating compositions containing the same |
| 04/22/2008 | US7361769 Metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 04/22/2008 | US7361675 1,2,4-thiadiazole compounds and use thereof |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/17/2008 | WO2008045558A2 Benzothiadiazine compounds and their use |
| 04/17/2008 | WO2008022286A3 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 04/17/2008 | US20080091009 Photocoupling; cyclization and sulfonimidation of disulfonyl fluoride compound by reaction with ammonia; heating, alkylation, electrolysis, quaternization, salt formation; chemical intermediates |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN100381936C Linked dihydrazone-based charge transport compounds |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358344 Azo dye |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/10/2008 | WO2008042928A2 Oxadiazole and thiadiazole derivatives as mitotic kinesin inhibitors and methods of use thereof |
| 04/10/2008 | WO2008020256A3 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use |
| 04/10/2008 | WO2007026376A3 A novel process for preparation of highly pure crystalline hydrochlorothiazide |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/09/2008 | EP1908755A1 Therapeutic agent for restenosis |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | CN101157690A 1-thia-2- hydrocarbon imino-3,4-diaza-9- oxa (aza )-10-oxo spiro [4.15]-3- eicosanic, preparation method and usage as fungicide |
| 04/09/2008 | CN101157665A Method for preparing terbufos benzthiazuron |
| 04/09/2008 | CN100379415C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/08/2008 | US7354944 protein kinase B inhibitors; abnormal cell growth, cancer, inflammation, and metabolic disordersp; 3-(3-Fluoro-phenyl)-N-[5-(3-methyl-1H-indazol-5-yl)-[1,3,4]thiadiazol-2-yl]-propane-1,2-diamine |
| 04/03/2008 | WO2008039023A1 Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists |
| 04/03/2008 | WO2008038841A1 Thiadiazolone derivative and use thereof |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081812 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders |
| 04/02/2008 | EP1904467A1 Urea glucokinase activators |
| 04/02/2008 | CN101155777A Method for producing disulfonyl fluride compound |
| 04/02/2008 | CN101153028A Compounds with antimicrobial antiviral activity |
| 04/01/2008 | US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents |
| 03/27/2008 | US20080076188 Luminescent compounds |
| 03/26/2008 | CN101148440A 1,3,4-thiadiazoles derivatives with insect disinfestations effect and preparation method and application thereof |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348345 Nonnucleoside reverse transcriptase inhibitors |
| 03/25/2008 | US7348017 such as 2-[Benzyl[(4-methoxyphenyl)sulfonyl]amino]-N-(3-thioxo-3H-1,2,4-dithiazol-5-yl)acetoamide; cosmetics; antiaging agents |
| 03/20/2008 | WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 03/20/2008 | WO2008032858A2 Thiadiazole compound and use thereof |
| 03/20/2008 | WO2008031534A1 Insecticidal compounds |
| 03/20/2008 | WO2008019090A3 Agonists of the sphingosine-1-phosphate receptor |
| 03/20/2008 | WO2008016692A3 Chemical compounds |
| 03/20/2008 | WO2007115058A3 Thiadiazolidinone inhibitors of ptpase |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080070895 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase |
| 03/20/2008 | US20080070885 disorders related to beta-amyloid such as Alzheimer's disease, Down's Syndrome, memory and cognitive impairment, dementia, amyloidosis; (2R,4S) N-Butyl-4-hydroxy-2-methyl-4-((10S,13S)-10-methyl-8,11-dioxo-2-oxa-9,12-diaza-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-13-yl)-butyramide for example |
| 03/20/2008 | US20080070866 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 03/20/2008 | CA2660611A1 Thiadiazole compound and use thereof |
| 03/19/2008 | EP1654241B1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 03/18/2008 | US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/12/2008 | EP1896436A2 Histone deacetylase inhibitors |
| 03/12/2008 | EP1708713B1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 03/12/2008 | CN101142199A [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and N A D P H quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in |
| 03/12/2008 | CN101142197A N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 03/12/2008 | CN100374427C Cyclic compound, process for producing the same, and pest control agent |
| 03/11/2008 | US7342037 Anti-inflammatory medicaments |
| 03/11/2008 | US7342031 5-(2,2-dimethyl-1,3-dioxolane-4-yl)methoxy-3-(4-methylbenzyl)thio-1,2,4-thiadiazole; pesticide and insecticide; more efficient arthropod pests controlling activity; against spodoptera, helicovepa, heliothis, mosquitoes, flies, weevils, darkling beetles... |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058319 Fused ring heterocycles as potassium channel modulators |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | CN101137363A [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/04/2008 | US7338968 inhibitors of IL-8 receptor binding; cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke, ischemia reperfusion injury, pain; novel antiinflammatory, antitumor agents |